Israel Biotech Fund II L.P. 13D and 13G filings for MediWound Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-05 06:16 am Purchase | 2022-11-28 | 13G | MediWound Ltd. MDWD | Israel Biotech Fund II L.P. | 816,793 12.300% | 816,793 (New Position) | Filing |